Skip to Main Content

Trainees

The primary aim of our Career Development Core is to provide qualified PhD and MD junior faculty members with salary support and translational team mentorship to enhance their research career development focused on women’s health and alcohol use.

With grant and in-kind funds from our medical school, we are supporting Yale-SCORE Early Investigators (meeting NIH criteria for Early-Stage Investigators). The Yale-SCORE supports 50% of their faculty effort.

SCORE Trainees

  • Assistant Professor of Psychiatry

    Yasmin Zakiniaeiz PhD received 50% salary support from the Core (2020-2022), to develop her program of research focused on multi-modal neuroimaging to examine sex differences in alcohol use. As indicators of her success:

    • K01 from NIAAA “Sex Differences in Alcohol Use Disorder Neurodegeneration using Multimodal PET and DTI Neuroimaging.”
    • McManus Trust Charitable Trust Grant titled “Imaging sex differences in dopamine and synaptic density in alcohol use disorder.”
    • Promoted to Assistant Professor in Psychiatry (Traditional Tenure Track) and negotiated $1M start-up package.
    • Enoch Gordis Award from the Research Society on Alcoholism, for outstanding research by a junior scientist.
    • Early Career Award from the American College of Neuropsychopharmacology (ACNP), for outstanding junior faculty research.
    • Published 16 peer reviewed papers linked to the SCORE
  • Assistant Professor of Psychiatry

    MacKenzie Peltier PhD is an Assistant Professor in the Department of Psychiatry with expertise in human pharmacology. Dr. Peltier received two years of 50% salary support to focus on the effect of ovarian hormones and neurosteroids on alcohol use disorder. Her translational mentorship team includes Sherry McKee PhD and Ismene Petrakis MD. Her progress includes:

    • VA-based career award (Veteran’s Affairs VISN1 Career Development Award) “Brexanolone to target stress-induced alcohol use among men and women Veterans with Posttraumatic Stress Disorder (PTSD).”
    • Pilot grant from National Center for PTSD “Semaglutide to reduce food/alcohol cue reactivity among trauma exposed veterans.”
    • Department of Defense Grant “Brexanolone to target concurrent Posttraumatic Stress Disorder (PTSD) and stress-induced alcohol use in Veterans: A dose finding study.” $1.2 million.
    • Guest Edited Special Issue on Women & Alcohol, Current Addiction Reports.
    • Published 31 peer reviewed papers linked to the SCORE
  • Assistant Professor of Medicine (Digestive Diseases); Translational Research Director of the Metabolic Health and Weight Loss Program, Digestive Diseases

    Bubu Banini MD/PhD, is an Assistant Professor of Medicine. Dr. Banini began translational research as an undergraduate student, subsequently pursuing a combined MD/PhD in genetics and molecular biology. After residency and chief residency in internal medicine, her interest in research led her to a postdoctoral research fellowship at Mayo Clinic in Minnesota where she studied mechanisms of liver inflammation, fibrosis and hepatocellular cancer. She continued this research with a four-year NIH-sponsored T-32 research/clinical fellowship in Gastroenterology and Hepatology at the Virginia Commonwealth University (VCU). There she studied basic and translational research in liver inflammation and fibrosis. Dr. Banini then pursued an additional year of training in transplant hepatology and was involved in developing standards and guidelines for liver transplant candidacy in patients with severe AH.

    Dr. Banini is mentored by Drs Ismene Petrakis, Wajahat Mehal, and Vasilis Vasiliou. Dr. Banini is currently completing her first year of 50% salary support. Her progress includes:

    • R01 from NIDDK “Oral digoxin for the treatment of NASH”. $3 million.
    • 2023 Yale Cancer Disparities Award titled “Reducing disparities in liver cancer outcomes in Connecticut” $125,000.
    • Developed and organized YCARE (Yale Conference for Alcohol Research and Education) with the aim to increase education and collaboration among healthcare professionals, researchers, and stakeholders in the Northeast region. The 2023 conference was attending by 110 participants, including NIAAA staff.
    • Appointment to Associate Director, Clinical and Translational Core, Yale Liver Center.
    • Appointment to National Medical Visionary Board, American Liver Foundation
    • Clinical Research Leadership Training, American College of Gastroenterology, 2024.
  • Assistant Professor of Psychiatry, and of Biomedical Informatics and Data Science

    Hang Zhou PhD is an Assistant Professor of Psychiatry and trained in computational biology. The focus of Dr. Zhou’s work is to understand the human genome and how it affects human traits and diseases. Dr. Zhou’s mentorship team includes Marc Potenza MD, and Joel Gelernter MD. Dr. Zhou is currently receiving his first year of 50% salary support. His progress includes:

    • Zhou H, et al. Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. Nature Medicine. PMCID: PMC9901058. This paper has received much media attention.
    • Promoted to Assistant Professor, Dept of Biomedical Informatics & Data Science.
    • Pilot grant from Yale CTNA “Genetics of sex differences in alcohol use and alcohol use disorder.” (co-funded with SCORE)
    • Pending NIAAA R01 “Genetics of sex differences in alcohol use and alcohol use disorder”; 2 other pending R01s (NCI, NIMH).
  • Associate Research Scientist of Psychiatry

    Robert Kohler PhD, is an Associate Research Scientist in Psychiatry, trained as a behavioral neuroscientist. His current work has been focused on computational methods to identify risk factors for the emergence of psychopathology during development in humans. Dr. Kohler’s mentorship team includes Sara Yip PhD, Sherry McKee PhD, and Graeme Mason PhD. Dr. Kohler is currently receiving his first year of 50% salary support. His progress includes:

    • K01 to NIAAA pending “Identification of whole-brain functional and structural brain networks following a priming dose of alcohol.”
    • Early Career Travel award from College of Problems on Drug Dependence, 2024.
    • Preprocessed and collated data from 5 NIAAA-led medication trials to examine sex differences in treatment trajectories. Papers based on this data are under review.
    • Presented in RSA 2024 symposium “Data-driven predictions of drinking during treatment for alcohol use disorder”
  • Postdoctoral Associate

    Vernon Garcia-Rivas PhD, is currently a trainee in Marina Picciotto’s laboratory who received his PhD in neuroscience from the University of Bordeaux, France. Recent progress includes:

    • Garcia-Rivas, V., Thomas, M.A., Soares, A.R., Picciotto, M.R. and Mineur, Y.S. “Involvement of the Basolateral and Central Amygdala in Stress-induced Ethanol Intake in Female Mice”, presented at the Society for Neuroscience Conference, Washington DC, Nov 11-15 2023.
    • Garcia-Rivas, V., Soares, A.R., Thomas, M.A., Mineur, Y.S. and Picciotto, M.R “Stress-induced Escalation of Ethanol Intake in Female Mice Requires Functional Microglia”, presented at the Research Society on Alcohol Annual Meeting, Bellevue WA, Jun 24-28 2023.
  • Nathalie Barrios is a graduate student from Clarkson University, who completed a dual-degree in Psychology and Mathematics. She is currently part of Yale’s Post-Baccalaureate Research Education Program (PREP) which helps students from underrepresented groups gain the skills and credentials necessary for advanced graduating training. With Career Enhancement funds, we were able to support an additional slot on this program, allowing Nathalie to join Dr. Kelly Cosgrove’s laboratory for a 1-year period. Nathalie’s training has been focused on sex differences, alcohol use disorder, and neuroimaging. At the completion of her training as part of the Yale-SCORE, Nathalie plans to begin a PhD program in Neuroscience to continue her research-focused career.

Pilot Funding

SCORE Pilot Projects ($50,000 per year budgeted; ~$20,000 per pilot).

Title Presentations, Awards, Papers, Funding
Metabolomics analysis of sex differences in alcohol-associated liver disease. Samuel Kushlan Award for Research Excellence; R01DK134624
Effect of lipopolysaccharide (LPS; endotoxin) on alcohol self-administration in females and males with AUD. RSA symposium presentation; R03AA028361
Sex Differences in the Kappa Opioid Receptor System in Alcohol Use Disorder. RSA oral presentation; RSA Enoch Gordis Award; K01AA029706; McManus Trust Grant
Brexanolone to target stress-induced alcohol use among males and females with PTSD and AUD. PASA oral presentation; National PTSD Center oral presentation; VA Career Award; Dept of Defense funding (DoD) ($1.2M)
Imaging Sex Differences in the Neuroimmune Response to Alcohol. Winter Conference on Brain Research oral presentation; PMC10743097; NIHMS1879430; R21AA030380; K99AA032043 (Prim Mentor; pending)
Genetics of sex differences in alcohol use disorder PMC11030482; PMC10719093; R01AA031025 (pending); R35GM157047 (pending)
Developing sex-specific machine learning models to predict relapse in females and males completing AUD treatment. PMC9180421; Alkermes Pathways Research Grant; R01AA031959
In vivo imaging of amygdala neural networks to elucidate sex differences in effects of ethanol and stress RSA oral presentation; PMC9704113; grant application in development
In vivo imaging of ACh release in the basolateral amygdala during sex-dependent stress-induced ethanol intake PMC10542494; PMC10616967; grant application in development
Developing predictive models to detect sex differences psychopathology from actigraphy data in the UK Biobank. Underway
Selective inhibition of 11β-HSD1 through glucocorticoid target will prevent female-specific stress-induced escalation of alcohol drinking in mice. Underway
Integrating addiction care for women with steatotic liver disease Underway

Summary of Pilot Project Mechanism:

FIG. 1. Grants—Twelve pilot projects funded by the SCORE Career Enhancement Program totaling $225,500 resulted in 14 extramural (4 NIH K-type, 7 NIH R-type, 3 Foundation) grants totaling $17,820,780.

Overall, our pilot funding mechanism has been highly successful. We have funded projects focused on molecular biology, neuroimaging, genetics, medication development, and machine learning on topics relevant to the primary scientific aims of our SCORE grant. A major goal of the pilot project program is to provide junior investigators with data to support K and R funding mechanisms.

We have evaluated our pilot program and across our prior and current SCORE grants (P50DA033945; U54027989). For every $1 invested in pilot funding, this has translated to $80 in extramural funding to junior investigators.

See Zakiniaeiz Y, Peltier MR, Mineur YS, Gueorguieva R, Picciotto MR, Petrakis I, Cosgrove KP, McKee SA. Developing Researchers with Expertise in Sex as a Biological Variable through SCORE Career Enhancement Core Center Programs. J Womens Health (Larchmt). 2023 Aug;32(8):852-857. doi: 10.1089/jwh.2023.0015. PMID: 37585509; PMCID: PMC10457604.